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Transforming growth factor-beta 1 induces intestinal
myofibroblast differentiation and modulates their migration
Abstract
AIM: To investigate the effects of transforming growth factor beta 1 (TGF-beta 1) on the differentiation
of colonic lamina propria fibroblasts (CLPF) into myofibroblasts in vitro. METHODS: Primary CLPF
cultures were incubated with TGF-beta 1 and analyzed for production of alpha-smooth muscle actin
(alpha-SMA), fibronectin (FN) and FN isoforms. Migration assays were performed in a modified
48-well Boyden chamber. Levels of total and phosphorylated focal adhesion kinase (FAK) in CLPF
were analyzed after induction of migration. RESULTS: Incubation of CLPF with TGF-beta 1 for 2 d did
not change alpha-SMA levels, while TGF-beta 1 treatment for 6 d significantly increased alpha-SMA
production. Short term incubation (6 h) with TGF-beta 1 enhanced CLPF migration, while long term
treatment (6 d) of CLPF with TGF-beta 1 reduced migration to 15%-37% compared to untreated cells.
FN and FN isoform mRNA expression were increased after short term incubation with TGF-beta 1 (2 d)
in contrast to long term incubation with TGF-beta 1 for 6 d. After induction of migration, TGF-beta
1-preincubated CLPF showed higher amounts of FN and its isoforms and lower levels of total and
phosphorylated FAK than untreated cells. CONCLUSION: Long term incubation of CLPF with
TGF-beta 1 induced differentiation into myofibroblasts with enhanced alpha-SMA, reduced migratory
potential and FAK phosphorylation, and increased FN production. In contrast, short term contact (6 h)
of fibroblasts with TGF-beta 1 induced a dose-dependent increase of cell migration and FAK
phosphorylation without induction of alpha-SMA production.
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Abstract
AIM: To investigate the effects of transforming growth 
factor β1 (TGF-β1) on the differentiation of colonic 
lamina propria fibroblasts (CLPF) into myofibroblasts 
in vitro .
METHODS: Primary CLPF cultures were incubated 
with TGF-β1 and analyzed for production of α-smooth 
muscle actin (α-SMA), fibronectin (FN) and FN 
isoforms. Migration assays were performed in a 
modified 48-well Boyden chamber. Levels of total and 
phosphorylated focal adhesion kinase (FAK) in CLPF 
were analyzed after induction of migration.
RESULTS: Incubation of CLPF with TGF-β1 for 2 d 
did not change α-SMA levels, while TGF-β1 treatment 
for 6 d significantly increased α-SMA production. 
Short term incubation (6 h) with TGF-β1 enhanced 
CLPF migration, while long term treatment (6 d) of 
CLPF with TGF-β1 reduced migration to 15%-37% 
compared to untreated cells. FN and FN isoform mRNA 
expression were increased after short term incubation 
with TGF-β1 (2 d) in contrast to long term incubation 
with TGF-β1 for 6 d. After induction of migration, 
TGF-β1-preincubated CLPF showed higher amounts 
of FN and its isoforms and lower levels of total and 
phosphorylated FAK than untreated cells.
CONCLUSION: Long term incubation of CLPF with 
TGF-β1 induced differentiation into myofibroblasts with 
enhanced α-SMA, reduced migratory potential and 
FAK phosphorylation, and increased FN production. In 
contrast, short term contact (6 h) of fibroblasts with 
TGF-β1 induced a dose-dependent increase of cell 
migration and FAK phosphorylation without induction 
of α-SMA production.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
Transforming growth factor-β (TGF-β) is involved in 
multiple fundamental biological processes such as cell 
proliferation[1-3], cell migration[4-8], cell differentiation[9], 
extracellular matrix deposition[6,7,10,11], and immune 
responses[12]. TGF-β is secreted by a variety of  cells 
www.wjgnet.com
including platelets, monocytes, macrophages, and 
lymphocytes. It is thought to play a critical role in 
embryogenesis, host response to tumors, and the repair 
response that follows damage to tissues by immune and 
nonimmune reactions[8].
TGF-β not only affects remodeling during normal 
wound healing after tissue injury, but also enhances 
fibrogenesis. Therefore, it is an important mediator 
in multiple fibrotic diseases, including pulmonary 
fibrosis, liver fibrosis, chronic pancreatitis[12], and in 
stricture formation in Crohn’s disease (CD)[13]. Increased 
expression of  TGF-β , especially of  the isoform 
TGF-β1, has been demonstrated in fibrotic tissues and 
regions of  increased extracellular matrix deposition[12]. 
TGF-β changes the balance between extracellular matrix 
synthesis and degradation, inducing an increase in the 
synthesis of  matrix components and a parallel decrease 
in the matrix-proteolytic activity[11,12].
TGF-β is synthesized as a pro-form which can be 
activated by multiple mechanisms. After activation of  
latent TGF-β and binding to its receptors, the activated 
receptors phosphorylate and assemble cytoplasmic Smad 
proteins. Subsequently, Smad complexes move to the 
nucleus as transcriptional regulators[12,14].
TGF-β is also a potent chemoattractant for human 
dermal fibroblasts. Intact disulfide bonds and perhaps 
the dimeric structure of  TGF-β are essential for its 
ability to stimulate migration of  fibroblasts, since 
reduction of  TGF-β results in a marked loss of  its 
chemoattractant potency[8].
Fibroblast migration plays an important role in 
tissue formation and wound healing. Following injury, 
tissue repair takes place involving inflammation, new 
tissue formation and scar constitution[15]. Migration of  
fibroblasts into and through the extracellular matrix 
during the initial phase of  wound healing appears to be a 
fundamental component of  wound contraction. In recent 
studies, we found that colonic lamina propria fibroblasts 
(CLPF) conditioned media induce migration of  primary 
human CLPF in the modified Boyden chamber[16]. 
Furthermore, we demonstrated that fibronectin (FN) 
was mainly responsible for the autocrine induction of  
CLPF migration and was an essential requirement for 
the induction of  CLPF migration, since different growth 
factors enhanced CLPF migration only in the presence 
of  conditioned medium or recombinant FN[16]. Reduced 
and enhanced migratory potential of  CLPF correlated 
with decreased and increased amounts of  FN or FN 
isoforms, respectively[17]. FNs occur in up to 20 different 
isoforms as a result of  alternative splicing of  the primary 
transcript in the two homologous type Ⅲ domains 
named ED-A and ED-B and the one non-homologous 
repeat termed ⅢCS[18-22]. The ED-A and ED-B segments 
are either entirely included or excluded. The type Ⅲ 
repeat may be included, excluded, or partially included in 
FN[23-25].
The alternatively spliced FN isoforms show distinct 
functional differences. The expression of  FN containing 
ED-A and ED-B domains is significantly increased 
during physiological wound healing and pathological 
tissue fibrosis[26]. Changes in the migratory potential 
of  CLPF from patients with CD were associated with 
changes in FN isoform level, while the expression of  
integrin α5β1, the main FN receptor on the surface of  
CLPF, was unchanged[17].
The differentiation or activation of  fibroblasts into 
myofibroblasts is an important step in tissue repair. 
Transient appearance of  myofibroblasts is a feature of  
normal wound healing, but the persistence of  these 
activated cells is associated with excessive collagen 
deposition and fibrosis[9]. Their prolonged presence and 
over-representation are hallmarks in the pathophysiology 
of  tissue fibrosis[27]. TGF-β1 potently stimulates the 
production of  α-smooth muscle actin (α-SMA) and 
stress fiber formation in fibroblasts and therefore their 
differentiation into myofibroblasts[9].
Since the regulation of  migration and differentiation 
of  intestinal fibroblasts is an important mechanism 
during intestinal wound healing and fibrosis, the effect 
of  TGF-β1 on these processes and on FN and FN 
isoform production was investigated in this study.
MATERIALS AND METHODS
Patients
Primary CLPF cultures were obtained from endoscopic 
biopsies or surgical specimens taken from healthy areas 
of  the mucosa of  patients undergoing surveillance 
colonoscopy or surgery for colorectal carcinoma. The 
study was approved by the Ethics Committee of  the 
University of  Regensburg.
Isolation and culture of human colonic fibroblasts
Human CLPF were isolated and cultured as described 
earlier[28]. Briefly, mucosa from surgical specimens was cut 
into 1 mm pieces while the biopsies were used directly 
for the isolation of  CLPF. Epithelial cells were removed 
in Hank’s Balanced Salt Solution without Ca2+ and 
Mg2+ (PAA, Cölbe, Germany) with 2 mmol/L EDTA 
(SIGMA, Deisenhofen, Germany). The remaining tissue 
was rinsed and then digested for 30 min at 37℃ with 
1 mg/mL collagenase 1 (SIGMA), 0.3 mg/mL DNase 
I (Boehringer, Mannheim, Germany) and 2 mg/mL 
hyaluronidase (SIGMA) in PBS (Gibco, Karlsruhe, 
Germany). The isolated cells were cultured in 25 cm2 
culture flasks (Costar, Bodenheim, Germany) with 
DMEM containing 10% FCS, penicillin (100 IE/mL), 
streptomycin (100 µg/mL), ciprofloxacin (8 µg/mL), 
gentamycin (50 µg/mL) and amphotericin B (1 µg/mL). 
Non-adherent cells were removed by subsequent 
changes of  medium. The remaining cells were used 
between passage 3 and 8.
Incubation of CLPF with TGF-β1
CLPF were incubated for two days or six days with 0, 
0.1, 1, 10 and 50 ng/mL of  TGF-β1 (Biozol, Germany) 
in serum-free medium. The culture medium of  6 d 
treated cells was changed after 3 d and new TGF-β1 
was added for a further three days. Subsequently, cells 
were used for investigation of  α-SMA production, cell 
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migration, quantitative mRNA analysis, FN, and FAK 
production.
Wounding assay: Induction of CLPF migration with 
platelet derived growth factor-AB
CLPF were incubated for 6 d with or without 
10 ng/mL of  TGF-β1 (Biozol, Germany) in serum-
free medium. The medium was changed after three 
days and new TGF-β1 was added for a further three 
days. The cells cultured in 5 cm dishes were wounded 
with a comb, washed and incubated for a further 4 h 
with different concentrations of  platelet derived growth 
factor (PDGF)-AB (R&D Systems, Minneapolis, MN, 
USA; 0, 5, 10, and 20 ng/mL). Cells were harvested and 
used for quantitative analysis of  FN and FN splicing 
form mRNA and for Western blot analysis of  FN and 
FN-splicing form protein as well as levels of  total and 
phosphorylated FAK.
Immunocytochemical staining
For immunocytochemical staining of  α-SMA, 20 000 
cells were seeded onto LabTek® Chamber slides (Nunc, 
Wiesbaden, Germany) and fixed with ice-cold acetone. 
Immunocytochemical stainings were performed 
according to the manufacturer’s APAAP protocol 
(Dako, Hamburg, Germany). The anti α-SMA antibody 
(1:25, clone 1A4, Dako) was used to investigate the 
differentiation of  CLPF into myofibroblasts. IgG2a 
(MOPC-141, Sigma) was used as an isotype control.
Western blotting
Western blot analysis was performed as described 
earlier[17,29]. Protein detection was carried out with a 
specific antibody to α-SMA (clone 1A4, Dako, Hamburg, 
Germany) and incubation with peroxidase-conjugated 
secondary antibody. Protein bands were visualized 
using a commercial chemoluminescence detection kit 
(ECL Plus; Amersham) according to the manufacturer’s 
protocol. Loading was checked by Ponceau S staining.
For FN and FAK protein immunoblots specific 
antibodies to FN (1:1000; 35041A, Pharmingen), FN 
ED-A (1:400; clone IST-9, Abcam), FN ED-B (1:200; 
PhiloMab-2, Philogen), FAK (1:666; Chemicon), 
phosphoFAK (1:1000; Biosource) and β-actin (1:10 000; 
Chemicon) were used. After washing of  the membranes 
horseradish peroxidase-conjugated secondary antibodies 
(Santa Cruz, CA) were added and incubated with 
chemiluminescent substrate (ECL Plus; Amersham 
Biosciences, Arlington Heights, IL) for 5 min before a 
film (Amersham Biosciences) was exposed.
After exposure, the antibody was stripped from 
the membrane with Re-Blot Plus-Strong (Chemicon, 
Hofheim, Germany) for 15 min and the blot was blocked 
again with 5% milk in 0.1% Tween 20-TBS before using 
it for the next antibody.
Migration assays
Migration assays were performed in a modified 48-well 
Boyden chamber as described earlier[28]: A polycarbonate 
filter (8 µm pore size, polyvinylpyrrolidone-free, 
Gerbu Biotechnik, Gaiberg, Germany) divided the 
chamber into an upper and a lower compartment. 
Each test substance was placed in the wells of  
the lower compar tment in repl icates of  three. 
Conditioned media with or without PDGF-AB, IGF-
Ⅰ (R&D Systems), EGF (Biosource, Germany) 
or TGF-β1 (Biozol)  were tested.  DMEM high 
glucose medium with or without 1% bovine serum 
albumin (BSA, SIGMA) served as negative controls. 
A tota l  of  20  000 CLPF/wel l  in  DMEM high 
glucose medium with 1% BSA were seeded into 
the wells of  the upper compartment of  the Boyden 
chamber. The Boyden chamber was incubated at 
37℃ in 10% CO2 atmosphere for 6 h. The filter was 
removed from the chamber and the non-migrated cells 
on the upper side of  the filter were scraped off  with a 
rubber policeman. The migrated cells on the lower side 
of  the filter were fixed and stained with Hemacolor 
staining kit (Merck, Darmstadt, Germany) and counted 
in 4 microscopic high power fields of  view (hpf) at a 
400-fold magnification. Unless otherwise indicated, 
each experiment was repeated at least three times 
(n = 3).
Conditioned media
The culture medium was removed from a confluent 
CLPF monolayer. The cells were washed twice with PBS 
and subsequently cultured with DMEM lacking FCS 
for 24 h. The conditioned medium was centrifuged to 
remove all cell debris and stored at -20℃ for no more 
than 3 mo.
RNA isolation and cDNA synthesis
For the isolation of  total  RNA stimulated and 
unstimulated primary human CLPF cultures were 
washed twice with PBS. CLPF were scraped off, 
centrifuged for 5 min, and resuspended with lysis buffer 
from the RNeasy® kit (Qiagen, Hilden, Germany). 
Total RNA was prepared from these CLPF according 
to the manufacturer’s protocol and stored at -80℃. The 
isolated RNA was reverse transcribed using the Promega 
Reverse Transcription System (Promega, Madison, WI, 
USA).
Quantitative mRNA analysis by real-time PCR
Amounts of  FN, ED-A and ED-B mRNA were 
quantified by real-time PCR as previously described[17].
Released reporter dye fluorescence during 40 cycles 
of  amplification was monitored using Sequence Detector 
software (SDS version 2.0, PE Applied Biosystems). 
Reporter dye fluorescence versus PCR cycles was 
plotted. A threshold was set in the exponential phase of  
the fluorescence curves. The threshold cycle numbers 
(Ct) were calculated.
Ct values of  GAPDH were subtracted from those of  
FN isoforms: dCt = Ct (FN isoforms) - Ct (GAPDH).
The mean value of  dCt values was calculated. The values 
of  cDNA from stimulated CLPF were subtracted from 
those of  untreated cDNA of  the same CLPF: ddCt = 
dCt (stimulated) - dCt (unstimulated). The relative start 
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amount of  cDNA was calculated in consideration of  the 
exponential amplification: x = 2-ddCt.
Statistical analysis
All data are given as mean ± SE. The Student’s t-test was 
used for analysis of  parametric data, while the Mann-
Whitney Rank Sum Test was used for evaluation of  non-
parametric data. Real time PCR data were pictured as 
boxplots. P < 0.05 were considered to be statistically 
significant.
RESULTS
Effect of TGF-β1 on α-SMA production of CLPF
To investigate the effect of  TGF-β1 on α-SMA 
production of  CLPF, CLPF were incubated with 
different concentrations of  TGF-β1 in serum-free 
medium. Subsequently, APAAP-staining of  α-SMA or 
its isotype control IgG2aκ was performed. Since there 
was no remarkable change in α-SMA production after 
treatment for one day or two days with 0.1, 1, and 10 
ng/mL TGF-β1 (data not shown), we compared α-SMA 
production of  CLPF incubated for two days (Figure 1A) 
or six days (Figure 1B) with 0, 10 and 50 ng/mL TGF-β1. 
A time- and dose-dependent increase of  α-SMA 
was observed: short-term treatment with 50 ng/mL 
TGF-β1 resulted in enhanced α-SMA production, 
however, after long-term incubation α-SMA was 
detected in almost all cells.
In order to confirm these results, Western blot 
analysis was performed (Figure 2A). CLPF treated 
for two days or six days with 10 ng/mL or 50 ng/mL 
TGF-β1 were lysed and levels of  α-SMA were detected. 
In each lane 30 µg/mL cell lysate protein were loaded 
and the loading was checked by Ponceau S staining 
(Figure 2B). Western blot data confirmed the induction 
of  α-SMA production by long-term incubation of  CLPF 
with TGF-β1 in contrast to short-term incubation, 
where no α-SMA was detected.
Effect of TGF-β1 on the migration of CLPF
Since TGF-β1 potently stimulated the production 
of  α-SMA in CLPF and as a consequence their 
differentiation into myofibroblasts, we investigated the 
effect of  long term TGF-β1 incubation on the migration 
of  CLPF. Because 10 ng/mL TGF-β1 induced similar 
α-SMA levels as 50 ng/mL TGF-β1 (Figure 2), we 
treated CLPF for six days with 10 ng/mL TGF-β1 and 
performed migration assays in the presence of  PDGF-
AB, IGF-Ⅰ, EGF and TGF-β1 diluted in 24 h CLPF-
conditioned medium in a modified Boyden chamber 
(Figure 3). The Boyden chamber was incubated at 37℃ 
in 10% CO2 atmosphere for 6 h. We reported earlier 
that growth factors like PDGF-AB, IGF-Ⅰ, EGF and 
TGF-β1 diluted in conditioned media enhance CLPF 
migration[28]. However, pre-incubation of  CLPF with 
TGF-β1 for six days significantly decreased CLPF 
migration. This decreased migratory potential of  
myofibroblast-like CLPF could not be re-enhanced by 
addition of  growth factors (Figure 3).
Migration assays with different dilutions of  PDGF-
AB in conditioned medium showed that short-term 
incubation (6 h) in the modified Boyden chamber 
enhanced migration of  TGF-β1-untreated CLPF in 
a dose-dependent manner (Figure 3A). Addition of  
5 ng/mL PDGF-AB to CLPF conditioned medium 
increased migration up to 60% (64 ± 5 cells/hpf) when 
compared to conditioned medium without additional 
PDGF-AB (control, 44 ± 4 cells/hpf). Addition of  
20 ng/mL PDGF-AB to CLPF conditioned medium 
induced a more than two-fold migration rate (121 ± 19 
cells/hpf) when compared to control. Pre-incubation 
of  CLPF for six days with 10 ng/mL TGF-β1 reduced 
migration to 37% (16 ± 2 cells/hpf) when compared to 
untreated CLPF (44 ± 4 cells/hpf) and could not be re-
enhanced by PDGF-AB (P < 0.0001; Figure 3A).
Similar results were obtained in migration assays 
using different concentrations of  IGF-Ⅰ, EGF or 
TGF-β1 in conditioned medium (Figure 3B-D). 
Addition of  the growth factors to the conditioned 
medium enhanced the migration of  TGF-β1-untreated 
CLPF, although the effect was not as strong as with 
PDGF-AB. Again, pre-incubation of  CLPF for six days 
with TGF-β1 led to a reduced migratory potential of  the 
cells and could not be re-enhanced by the growth factors 
IGF-Ⅰ (Figure 3B: 100 ng/mL, P < 0.005; 200 ng/mL, 
P < 0.05; 300 ng/mL, P < 0.0001), EGF (Figure 3C: 
10 ng/mL, P < 0.05) or TGF-β1 (Figure 3D: 10 pg/mL, 
P < 0.005; 20 pg/mL, P < 0.0001; 30 pg/mL, P < 0.05).
Effect of TGF-β1 on the production of FN and FN isoforms
It is known that TGF-β1 promotes the insertion of  the 
ED-A domain in FN[30,31] and we have recently shown 
that changes in the migratory potential of  CLPF were 
correlated with changes in FN isoform production[17]. 
For this reason, the effect of  TGF-β1 on splicing of  FN 
mRNA in CLPF was assessed. CLPF were incubated 
with different TGF-β1 concentrations for two days or 
six days and the amounts of  FN, FN ED-A-, and FN 
ED-B were determined. Therefore the cells were treated 
with 10 ng/mL and 50 ng/mL TGF-β1 and untreated 
cells were used as controls. For the comparison of  
mRNA expression quantified by real time PCR untreated 
controls were set as 1. The results of  7 independent 
experiments were evaluated statistically (Figure 4).
After two days incubation with 10 ng/mL TGF-β1 
total FN mRNA expression was increased 20-fold and 
25-fold with 50 ng/mL (both P < 0.005, paired t-test). 
When CLPF were incubated for six days, FN mRNA 
was increased 6-fold with 10 ng/mL TGF-β1 and 
10-fold with 50 ng/mL TGF-β1 compared to control 
(Figure 4A).
mRNA amounts of  FN ED-A and FN ED-B were 
increased 20-fold (P < 0.05) and 13-fold (P < 0.005), 
respectively, with 10 ng/mL TGF-β1 after two days, 
while after six days 5-fold (FN ED-A, P < 0.05) or 
3-fold (FN ED-B, P < 0.05) increased mRNA levels 
compared to controls were found (Figure 4B and C). 
Treatment with 50 ng/mL TGF-β1 for 2 d caused a 
23-fold (P < 0.01) increase of  FN ED-A mRNA which 
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was reduced to 6-fold after a further four days. mRNA 
amounts of  FN ED-B was 15-fold (P < 0.01) after two 
days and reduced to 4-fold (P < 0.05) after six days 
(Figure 4B and C).
Together these data indicate that TGF-β1 causes 
a strong increase in mRNA expression of  FN and 
migration inducing FN isoforms. However, this effect 
was not maintained but was clearly reduced after six 
days. Values obtained after six days of  incubation were 
not statistically different to unstimulated controls despite 
the presence of  TGF-β1. On average, FN mRNA 
amounts were 70% lower after pre-incubation with 10 
ng/mL TGF-β1 for six days than after pre-incubation 
for two days (P < 0.05), while FN ED-A and FN ED-B 
(P < 0.05) mRNA levels were reduced by 80%. Similar 
data were obtained for incubation with 50 ng/mL 
2 d TGF-β1
0 ng/mL TGF-β1 α-actin staining 10 ng/mL TGF-β1 α-actin staining 50 ng/mL TGF-β1 α-actin staining
Isotype IgG2aκ Isotype IgG2aκ Isotype IgG2aκ
A
6 d TGF-β1B
0 ng/mL TGF-β1 α-actin staining 10 ng/mL TGF-β1 α-actin staining 50 ng/mL TGF-β1 α-actin staining
Isotype IgG2aκ Isotype IgG2aκ Isotype IgG2aκ
Figure 1  Effect of TGF-β1 on α-SMA production in CLPF. CLPF were incubated for 2 d (A) or 6 d (B) with 0, 10 and 50 ng/mL TGF-β1. Subsequently, APAAP-
staining of α-SMA (α-actin) or its isotype control IgG2a was performed. Incubation of CLPF for 6 d with 10 ng/mL or 50 ng/mL TGF-β1 showed the greatest effect on 
α-SMA, since almost all cells showed a red stainining for α-SMA.
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TGF-β1 for six days versus stimulation for two days (total 
FN 55% lower (P < 0.05) after six days compared to two 
days, FN ED-A and FN ED-B 75% lower (P = 0.05).
In addition, TGF-β1-mediated induction of  FN 
and FN splice variant production was confirmed by 
Western blot analyses. A time- and dose-dependent 
increase of  total FN, FN ED-A and FN ED-B was 
detected after TGF-β1 treatment (Figure 5). In contrast 
to the findings for mRNA expression after six days TGF 
treatment higher levels of  FN, ED-A and ED-B protein 
compared to two days were observed. In the absence 
of  TGF-β1, levels of  FN and FN isoforms were low 
and did not differ between two- and six- day cultures. 
A concentration of  0.1 ng/mL TGF-β1 did not show 
a significant effect while 1 ng/mL TGF-β1 induced an 
increase in FN and FN ED-A production after two days 
and six days compared to untreated cells. After two days 
FN ED-B protein was only found after incubation with 
TGF-β1 concentrations of  10 ng/mL and 50 ng/mL, 
while this isoform could be detected after six days with 
1, 10, and 50 ng/mL TGF-β1. The most prominent 
effect on FN, FN ED-A, and FN ED-B production 
was observed after six days incubation with 50 ng/mL 
TGF-β1.
Effects of TGF-β1 and PDGF-AB on FN and FN isoforms 
in a wounding model 
Because of  the observed reduced migratory potential of  
CLPF incubated long-term with TGF-β1 but increased 
protein levels of  migration inducing factor FN and FN 
splice variants, we analyzed migrating cells in a wounding 
assay in more detail. CLPF were pre-incubated with and 
without 10 ng/mL TGF-β1 in serum free medium (six 
days). The CLPF monolayer was wounded with a comb, 
migration was induced by incubation with different 
concentrations of  PDGF-AB (0, 5, 10, 20 ng/mL) in 
conditioned medium for 4 further hours and mRNA 
amounts of  FN isoforms were assessed (Figure 6).
While CLPF without TGF-β1 pre-treatment 
displayed a slight PDGF-dependent increase in the 
expression of  FN, FN ED-A, and a slight decrease in 
FN ED-B mRNA in this wounding assay, TGF-β1 pre-
treated cells displayed a stronger enhancement of  FN, 
FN ED-A, and FN ED-B mRNA-expression. 
After stimulation with 5, 10, and 20 ng/mL PDGF-
AB in conditioned medium FN mRNA-expression was 
4.5- (Paired t-test, P < 0.05), 4- (P < 0.01), and 4.5-fold 
(P < 0.05) increased in TGF-β1 pre-treated and 2-, 
3.5-, and 1.5-fold enhanced in TGF-β1 untreated CLPF 
as compared to the control, respectively (Figure 6A). 
PDGF-AB stimulation of  pre-incubated CLPF led to 3- 
(5 ng/mL PDGF, P < 0.005), 2.5- (10 ng/mL PDGF, 
P < 0.01), and 4-fold increases (20 ng/mL PDGF, P < 
0.05) in FN ED-A mRNA expression, whereas TGF-β1 
unstimulated cells showed a 2- (P < 0.05), 3.5-, and 
1.5-fold enhancement, respectively (Figure 6B). PDGF 
caused a 3- (5 ng/mL, P < 0.01), 2.5- (10 ng/mL, P < 
0.01), and 3-fold increase (20 ng/mL, P < 0.01) in FN 
ED-B mRNA in TGF-β1-treated CLPF and a 1.5-, 2.5- 
(5 and 10 ng/ mL, P < 0.01), and 1.5-fold (20 ng/mL) 
enhancement in TGF-β1 untreated cells (Figure 6C).
In summary, pre-treatment of  CLPF with TGF-β1 
(six days) and subsequent treatment with PDGF-AB 
(4 h) after wounding causes a much stronger induction 
of  FN mRNA expression than without TGF-β1 pre-
treatment.
After TGF-β1-incubation, wounding, and incubation 
without PDGF-AB mRNA levels of  total FN, FN 
ED-A, and FN ED-B increased significantly by 4-fold 
when compared to TGF-β1- and PDGF-AB-untreated 
controls (P < 0.05 for FN and FN ED-A; FN ED-B P 
< 0.005). With 5 ng/mL PDGF-AB mRNA amounts 
of  FN splice forms doubled by TGF-β1-stimulation 
[FN ED-A (P < 0.05)]. After TGF-β1 pre-stimulation 
expression of  FN and FN ED-B rose by 20% compared 
to untreated cells, while FN ED-A expression was 
even decreased by 30%. With 10 ng/mL TGF-β1 and 
20 ng/mL PDGF-AB, after cell wounding total FN 
expression showed a 3-fold (P < 0.05), FN ED-A 
expression a 2.5-fold (P = 0.06), and FN ED-B 
expression a 2-fold (P < 0.005) increase.
Western blot analyses of  protein production 
confirmed these findings on mRNA expression (Figure 7). 
Protein amounts of  FN, FN ED-A, and FN ED-B 
were strongly increased by TGF-β1 incubation. In 
comparison to TGF-β1 untreated controls the levels 
of  FNs were enhanced after wounding and further 
enhanced by addition of  PDGF-AB in conditioned 
medium. No significant differences were observed 
between protein amounts in TGF-β1 pre- and not 
incubated CLPF by PDGF-treatment, respectively. FN 
A 51
M         0        10       50      M      0        10      50
ng/mL TGF-β1 for 2 d ng/mL TGF-β1 for 6 d
B
M         0        10       50      M      0        10       50
ng/mL TGF-β1 for 2 d ng/mL TGF-β1 for 6 d
51
39
Figure 2  Effect of TGF-β1 on α-SMA protein production. Control CLPF 
were incubated for 2 d or 6 d with 0, 10, and 50 ng/mL TGF-β1 in serum-free 
medium. Subsequently the cells were washed and lysed. Amounts of α-SMA 
were analyzed by Western blotting (A). Equal loading was confirmed by Pon-
ceau S staining (B). Incubation of CLPF for 6 d with 10 ng/mL or 50 ng/mL 
TGF-β1 markedly enhanced α-SMA production.
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ED-B protein levels of  CLPF without pre-treatment 
were barely detectable.
Effects of  TGF-β1 on FAK phopshorylation in a 
wounding model
We have demonstrated in previous studies that enhanced 
cell migration of  CLPF was associated with higher FAK 
phosphorylation and total FAK protein production[29]. 
Therefore, we determined TGF-β1-modulated FAK 
production and phosphorylation by Western blot (Figure 8) 
in CLPF that were induced to migrate by wounding and 
stimulation with PDGF-AB in conditioned medium. 
Pre-incubation of  CLPF with 10 ng/mL TGF-β1 for 
six days decreased FAK phosphorylation as compared 
to untreated controls. In addition, levels of  FAK protein 
were reduced by TGF-β1 stimulation. CLPF that were 
not pre-treated with TGF-β1 contained enhanced levels 
of  FAK with a constant higher FAK phosphorylation 
that was highest with an addition of  5 ng/mL PDGF-
AB when compared to CLPF not treated with TGF-β1.
DISCUSSION
In this study we demonstrate that TGF-β1 potently 
stimulates the production of  α-SMA in CLPF and 
therefore their differentiation into myofibroblasts as a 
result of  long term contact. This differentiation into 
myofibroblasts is accompanied by a reduced migratory 
potential, reduced FAK phosphorylation and increased 
synthesis of  FN as a component of  extracellular matrix 
(ECM).
Myofibroblast differentiation and activation by 
TGF-β1 is a critical event in tissue repair and the 
pathogenesis of  human fibrotic diseases. Myofibroblasts 
and TGF-β1 are key elements for the generation of  
contractile force associated with wound contraction 
and pathological contractures as in the development of  
tissue fibrosis. Myofibroblasts are characterized by the 
presence of  α-SMA-containing stress fibers, vinculin-
containing fibronexus adhesion complexes, and FN 
fibrils containing the ED-A splice variant[32]. TGF-β1 
promotes contraction of  collagen gels by fibroblasts 
through their differentiation into myofibroblasts[33]. In 
addition, TGF-β1 induces a dose-dependent increase in 
the generation of  contractile force and a concomitant 
increase in the production of  α-SMA[32].
In the current study much higher TGF-β1 doses 
were required to induce α-SMA production than in the 
studies by Simmons et al[9] and Vaughan et al[32]. This 
may be a cell-type-specific effect. Simmons et al. used 
CCD-18Co fibroblasts isolated from the colon of  a 
2.5 mo old child, while in this study intestinal 
fibroblasts of  adults have been used. Vaughan et al[32] 
used myofibroblasts obtained as explant cultures or 
by collagenase digestion of  palmar aponeurosis from 
patients with Dupuytren’s disease. Therefore, it may be 
Figure 3  Effect of TGF-β1 on growth factor-induced migration of CLPF. Control-CLPF were treated for 6 d with 10 ng/mL TGF-β1 and subsequently migration 
assays in the presence of PDGF-AB, IGF-Ⅰ, EGF and TGF-β1 diluted in 24 h CLPF-conditioned medium were performed in the modified Boyden chamber. TGFβ1 
treatment of CLPF significantly decreased the migratory potential, which could not be re-enhanced by cell migration-inducing growth factors. Statistics: The Mann-
Whitney Rank Sum Test was used for the evaluation of the non-parametric data. A: bP < 0.0001 vs unstimulated CLPF; B: cP < 0.05, dP < 0.005 vs unstimulated CLPF; 
C: eP < 0.05 vs unstimulated CLPF; D: gP < 0.05, hP < 0.01 vs unstimulated CLPF.
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that fibroblasts obtained from palmar aponeurosis react 
more sensitively to TGF-β1 than CLPF.
Myofibroblast differentiat ion by TGF-β1 is 
dependent on cell adhesion and integrin signaling via 
FAK. TGF-β1 induces tyrosine phosphorylation of  the 
autophosphorylation site Tyr-397 of  FAK, an effect 
that is dependent on cell adhesion and is delayed relative 
to early Smad signaling. Pharmacologic inhibition of  
FAK or expression of  kinase-deficient FAK, mutated 
by substituting Tyr-397 with Phe, inhibited TGF-β1-
induced α-SMA production and stress fiber formation[34]. 
In the current study we found that long term incubation 
with TGF-β1 reduced FAK phosphorylation and this 
was associated with a decreased migratory potential. 
TGF-β1 untreated CLPF displayed a PDGF-dependent 
increase of  FAK-phosphorylation that correlated with 
an enhanced migration.
FAK is a nonreceptor protein tyrosine kinase 
involved not only in adhesion but also in cell migration. 
FAK-deficient fibroblasts exhibit defects in cell 
migration and elevated numbers of  cell-substratum 
contact sites[35]. The reduced migratory behavior of  CD- 
and ulcerative colitis (UC)-CLPF is accompanied by a 
reduction of  FAK and FAK phosphorylation[29].
TGF-β1 production is increased in myofibroblasts at 
sites of  fibrosis in experimental enterocolitis and CD[9]. 
In CD, increased TGF-β1 expression is transmural 
whereas in UC, the increase is confined to the lamina 
propria and submucosa. The distribution of  TGF-β1 
coincides with the distribution of  the inflammatory 
infiltrate as well as an increase in the collagen type Ⅲ:
Ⅰ ratio in both CD and UC[36]. Additionally, TGF-β1, 
-β2, -β3 and their receptors are increased in fibrotic CD 
mucosal tissue samples[13]. Therefore, it may be assumed 
that a reduced migratory potential of  inflammatory 
bowel disease (IBD)-CLPF[29] is a result of  enhanced 
α-SMA production and enhanced formation of  focal 
contacts induced by increased levels of  TGF-β1 in the 
tissue. However, we could not find higher α-SMA levels 
in ex vivo cultures of  CD- and UC-CLPF compared 
to cultures isolated from control mucosa (data not 
shown). Therefore, a differentiation of  IBD-CLPF 
into myofibroblasts was not the reason for the reduced 
migratory potential of  these cells.
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Figure 4  Quantitative mRNA analysis of FN (A) and the splicing forms 
FN ED-A (B) and FN ED-B (C) by real-time PCR in TGF stimulated CLPF. 
TGF-β1 stimulated and untreated control-CLPF (n = 7) were lysed and mRNA 
was isolated. The cDNA start concentration of the untreated control group was 
set as 1. Compared to the control cells a dose-dependent increase in mRNA 
expression of FN, FN ED-A, and FN ED-B was determined. TGF-β1-stimulation 
for 2 d caused a higher increase in FN mRNA expression than after 6 d. Paired 
t-test: aP < 0.005; bP < 0.01; cP < 0.05.
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       (ng/mL)
Figure 5  Effect of TGF-β1 on FN, FN ED-A, and FN ED-B protein in CLPF 
after 2 d and 6 d. Control-CLPF were incubated for 2 d or 6 d with 0, 0.1, 1, 10, 
and 50 ng/mL TGF-β1 in serum-free medium. Subsequently cells were washed 
and lysed. Amounts of FN were quantified by Western blotting. Loading was 
checked by β-actin production. Incubation of CLPF for 6 d with TGF-β1 mark-
edly enhanced the levels of FN, FN ED-A, and FN ED-B.
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Contrasting migration-modulating effects of  TGF-Β 
are described in the literature. Ellis et al[7] report a diverse 
pattern of  motogenic response to the three TGF-Β 
isoforms. Migration of  subconfluent fibroblasts into 3D 
collagen gels was inhibited by all three TGF-Β-isoforms, 
whereas migration of  confluent cells was unaffected 
by TGF-β1 and TGF-β2, but stimulated by TGF-β3[7]. 
Postlethwaite et al[8] reported that TGF-β1 is a potent 
chemoattractant in the Boyden chamber for human 
dermal fibroblasts. Inhibitory effects of  TGF-β1 on 
fibroblast migration into 3D collagen gels are in marked 
contrast to reports indicating that TGF-β1 stimulates 
the migration of  human skin fibroblasts in the modified 
Boyden chamber[6].
Previously we investigated the effect of  TGF-β1 
on CLPF migration in the modified Boyden chamber 
after a 6 h incubation period[28] and found a significant 
migration-inducing effect of  TGF-β1. Here we report 
that long term incubation for 6 d with TGF-β1 induces a 
marked reduction of  migration in subsequent migration 
assays. This discrepancy obviously was determined by 
the time TGF-β1 could act on the target cells.
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Figure 7  FN, FN ED-A, and FN ED-B protein levels of TGF-β1-pre-
stimulated and unstimulated control CLPF in a wounding assay. Isolated 
proteins were analyzed by Western blotting. Protein levels of FN, FN ED-A, 
and FN ED-B were increased by TGF-β1-pre-treatment compared to untreated 
control. Loading was checked by Ponceau S staining.
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Figure 8  Analysis of FAK phosphorylation and FAK protein production 
of CLPF after TGF-β1 incubation in a wounding assay. Isolated proteins 
were analyzed by Western blotting. Phospho-FAK and FAK decreased after 
6 d TGF-β1 pretreatment in comparison to untreated controls. Loading was 
checked by Ponceau S staining.
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Figure 6  Quantitative mRNA analyses of FN (A) and the splicing forms FN 
ED-A (B), and FN ED-B (C) by real-time PCR in CLPF treated with TGF-β1. 
Control CLPF (n = 7) were pre-incubated with and without 10 ng/mL TGF-β1 
for 6 d, the monolayer wounded with a comb, and incubated for further 4 h with 
increasing concentrations of PDGF-AB in conditioned medium. mRNA was iso-
lated and cDNA transcribed. cDNA start concentration of the untreated control 
(0 ng/mL TGF-β1 and 0 ng/mL PDGF-AB) was set as 1. Paired t-test: aP < 0.005; 
bP < 0.01; cP < 0.05.
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Addition of  10 ng/mL and 50 ng/mL TGF-β1 
resulted in a dose-dependent increase of  FN, FN ED-A, 
and FN ED-B expression. After two days incubation, 
expression of  FN and the splice forms significantly 
increased. Enhanced mRNA expression was also 
observed after 6 d incubation with TGF-β1 but was not 
as high as after 2 d. On the other hand, after six days 
higher protein levels of  total FN and FN isoforms were 
observed in comparison to the unstimulated two day 
control. Therefore, the reduced migration of  CLPF after 
six days incubation with TGF-β1 is accompanied by 
enhanced protein levels of  FN and FN isoforms. This 
increased production of  FN and FN isoforms might 
lead to enhanced cell adhesion. Other groups also report 
that fibroblast attachment is significantly increased after 
TGF-β1 treatment[36]. Nevertheless, cell adhesion was 
not addressed in our investigations.
In CLPF treated for six days with TGF-β1, after 
wounding and PDGF-AB incubation increased protein 
levels of  FN, FN ED-A, and FN ED-B were found 
when compared to untreated controls. In these cells 
FAK protein and FAK phosphorylation were reduced. 
This reduced FAK phosphorylation correlated with the 
observed reduced migratory potential after long term 
incubation with TGF-β1.
In conclusion, long term incubation of  intestinal 
fibroblasts with TGF-β1 induced differentiation into 
myofibroblasts with an enhanced α-SMA production 
and a reduced migratory potential that was accompanied 
by decreased FAK production and phosphorylation. 
In contrast, short term contact of  CLPF with TGF-β1 
induced a dose-dependent increase of  cell migration 
without induction of  α-SMA. Therefore, the following 
scenario is conceivable: after wounding TGF-β1 is 
produced by different cell types and connective tissue 
cells, like CLPF, migrate towards the wound along the 
TGF-β1 gradient. Long-term contact with TGF-β1 in 
the wound allows the fibroblasts to differentiate into 
myofibroblasts. Myofibroblasts support wound healing 
via wound contraction and production of  extracellular 
matrix deposition. In pathological situations the local 
increase in immigrated cell numbers with reduced 
dispersing potential and increased deposition of  
extracellular matrix may finally lead to tissue fibrosis. FN 
that is produced during the induction of  migration and 
secreted at the site of  injury may lead to an additional 
enhancement of  the migratory gradient (Figure 9). 
The phosphorylation of  FAK is reduced after longer 
contact with TGF due to the differentiation into ECM-
producing myofibroblasts.
However, this model remains speculative, since the 
modulating influence of  other factors on fibroblast 
migration and the complex interactions of  fibroblasts 
with immune cells or epithelial cells certainly play an 
important role in wound healing, too.
The role of  TGF-β and the mechanism of  mucosal 
wound healing or intestinal tissue fibrosis require further 
investigation to develop therapies for the modulation of  
the mucosal healing response in IBD.
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Figure 9  Schematic illustration of the role of TGF-β1, FN, and FAK in the development of fibrosis in CD. After wounding TGF-β1 is produced by different cell 
types and connective tissue cells. CLPF increase FAK phosphorylation and migrate into the wound along the TGF-β1 gradient. FN that is also produced during migra-
tion induction and secreted at the site of injury may lead to an additional enhancement of the migratory gradient. Long term contact with TGF-β1 within the wound 
allows fibroblasts to differentiate into myofibroblasts. These cells have a reduced migratory potential and support wound healing via wound contraction and production 
of extracellular matrix deposition like FN. Phosphorylation of FAK is reduced after longer contact with TGF-β1 due to the differentiation into ECM-producing myofibro-
blasts.
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Background
Migration of colonic lamina propria fibroblasts (CLPF) plays an important role 
during the progression of fibrosis and fistulae in Crohn’s disease. Transforming 
growth factor-β (TGF-β) is involved in the regulation of cell migration, cell 
differentiation, extracellular matrix deposition, and immune responses. In recent 
studies, the authors found that CLPF conditioned media induced migration 
of primary human CLPF and that fibronectin (FN) was mainly responsible for 
the autocrine induction of CLPF migration. Since the regulation of migration 
and differentiation of intestinal fibroblasts is an important mechanism during 
intestinal wound healing and fibrosis, the effect of TGF-β1 on these processes 
and on FN and FN isoform production was investigated in this study.
Research frontiers
A high number of patients with Crohn’s disease have to undergo surgery 
because of fibrotic disease. The mechanism of stricture formation and the role 
of TGF-β in this are not well understood.
Innovations and breakthroughs
This study adds to the understanding of the role of TGF-β in intestinal wound 
healing and stricture formation. It shows that TGF-β can both be beneficial and 
detrimental depending on the duration of secretion.
Terminology
Colon lamina propria fibroblasts (CLPF): CLPF are mesenchymal cells 
of connective tissue that are in an activated state and locally agile. After 
differentiation into myofibroblasts cells are in a less active state, concerned 
with maintenance. Transforming growth factor (TGF): TGF-β1 is a cytokine 
that on the one hand stimulates migration of fibroblasts and on the other hand 
potently stimulates the production of α-smooth muscle actin and stress fiber 
formation in fibroblasts and therefore their differentiation into myofibroblasts. 
Fibronectin (FN): FN is an extracellular matrix protein that is mainly responsible 
for the autocrine induction of CLPF migration and is essentially required 
for the induction of CLPF migration. Focal adhesion kinase (FAK): FAK is a 
nonreceptor protein tyrosine kinase involved not only in adhesion but also in 
cell migration. Enhanced migration of CLPF is associated with higher FAK 
phosphorylation and total FAK protein production. Myofibroblast differentiation 
by TGF-β1 is dependent on cell adhesion and integrin signaling via FAK. 
Peer review 
The authors investigated the effects of transforming growth factor-β (TGF-β) 
on the differentiation of colonic lamina propria fibroblasts (CLPF) into 
myofibroblasts in vitro. They found that long term incubation of CLPF with 
TGF-β1 induced differentiation into myofibroblasts with enhanced α-SMA, 
reduced migratory potential and FAK-phosphorylation, as well as increased 
FN production. In contrast, short term contact (6 h) of fibroblasts with TGF-β1 
induced a dose-dependent increase of cell migration and FAK-phosphorylation 
without induction of α-SMA production. The study is well designed, the methods 
they use are sound and their results are reliable.
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